Skip to main content
. 2026 Feb 20;9(2):447–456. doi: 10.31662/jmaj.2025-0208

Table 2.

Included Cases with Acute CO Poisoning and Polycythemia.

Acute CO poisoning Polycythemia
Number of cases 68 13
Country, n (%)
 North America 2 (2.9) 1 (7.7)
 Europe 45 (66.2) 4 (30.8)
 Middle East 17 (25.0) 1 (7.7)
 Africa 0 (0.0) 7 (53.8)
 Oceania 1 (1.5) 0 (0.0)
 Asia 3 (4.4) 0 (0.0)
Age, n (%)
 10-19 years 22 (32.4) 0 (0.0)
 20-29 years 33 (48.5) 6 (46.2)
 30-39 years 8 (11.8) 3 (23.1)
 40-49 years 3 (4.4) 1 (7.7)
 50-59 years 0 (0.0) 1 (7.7)
 Missing 2 (2.9) 1 (7.7)
Sex, N (%)
 Men 40 (58.8) 12 (92.3)
 Women 27 (39.7) 1 (7.7)
 Missing 1 (1.5) 0 (0.0)
Symptoms, N (%)
 Syncope 36 (52.9) 0 (0.0)
 Headache 34 (50.0) 1 (7.7)
 Dizziness 30 (44.1) 1 (7.7)
 Nausea or vomiting 26 (38.2) 0 (0.0)
 Weakness or collapse 10 (14.7) 1 (7.7)
 Impaired consciousness 9 (13.2) 3 (23.1)
 Injuries 5 (7.4) 0 (0.0)
 Shortness of breath 4 (5.9) 0 (0.0)
 Vertigo 3 (4.4) 0 (0.0)
 Chest pain 3 (4.4) 0 (0.0)
 Seizure 3 (4.4) 0 (0.0)
 PE or DVT 0 (0.0) 2 (15.4)
 Facial plethora 0 (0.0) 2 (15.4)
 Others 17 (25.0) 2 (15.4)
 None 2 (2.9) 2 (15.4)
 Missing 0 (0.0) 0 (0.0)
Onset of symptoms, N (%)
 During exposure 9 (13.2) 0 (0.0)
 Shortly after exposure 16 (23.5) 0 (0.0)
 Delayed after exposure 8 (11.8) 0 (0.0)
 No apparent symptoms 2 (2.9) 2 (15.4)
 Missing 33 (48.5) 11 (84.6)
COHb levels
 Number of valid cases 65 6
 Mean (SD) 22.2 (8.4) 24.6 (10.9)
 Missing, N (%) 3 (4.4) 7 (53.8)
Hb levels
 Number of valid cases 3 13
 Mean (SD) 15.5 (1.6) 20.5 (2.0)
 Missing, N (%) 65 (95.6) 0 (0.0)

CO: carbon monoxide; COHb: carboxyhemoglobin; DVT: deep vein thrombosis; Hb: hemoglobin; PE: pulmonary embolism; SD: standard deviation.